Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease

JW Zhang,1 WW Liu,1 Timothy A McCaffrey,2 XQ He,1 WY Liang,1 XH Chen,1 XR Feng,1 Sidney W Fu,2 ML Liu1 1Department of Geriatrics, Peking University First Hospital, Beijing, China; 2Department of Medicine, George Washington University Medical Center, Washington, DC, USA Objectives: Previous studies...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhang JW, Liu WW, McCaffrey TA, He XQ, Liang WY, Chen XH, Feng XR, Fu SW, Liu ML
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/c006466b426748b89b4de988d64cc73d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c006466b426748b89b4de988d64cc73d
record_format dspace
spelling oai:doaj.org-article:c006466b426748b89b4de988d64cc73d2021-12-02T03:21:22ZPredictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease1178-1998https://doaj.org/article/c006466b426748b89b4de988d64cc73d2017-08-01T00:00:00Zhttps://www.dovepress.com/predictors-of-high-on-aspirin-platelet-reactivity-in-elderly-patients--peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998JW Zhang,1 WW Liu,1 Timothy A McCaffrey,2 XQ He,1 WY Liang,1 XH Chen,1 XR Feng,1 Sidney W Fu,2 ML Liu1 1Department of Geriatrics, Peking University First Hospital, Beijing, China; 2Department of Medicine, George Washington University Medical Center, Washington, DC, USA Objectives: Previous studies have illustrated the link between high on-aspirin platelet reactivity (HAPR) with increasing thrombotic risks. The aim of our study was to investigate relative risk factors of HAPR in elderly patients with coronary artery disease.Methods: Elderly, hospitalized coronary artery disease patients on regular aspirin treatment were enrolled from January 2014 to September 2016. Medical records of each patient were collected, including demographic information, cardiovascular risk factors, concomitant drugs and routine biological parameters. Arachidonic acid (AA, 0.5 mg/mL) and adenosine diphosphate (ADP, 5 µmol/L) induced platelet aggregation were measured via light transmission assay (LTA) to evaluate antiplatelet responses, referred as LTA–AA and LTA–ADP.Results: A total of 275 elderly patients were included, with mean age of 77.2±8.1 years, and males accounted for 81.8%. HAPR was defined as LTA–AA in the upper quartile of the enrolled population. HAPR patients tended to have lower renal function (P=0.052). Higher serum uric acid (SUA) level, as well as lower platelet count, hemoglobin and hematocrit were observed in HAPR patients, with a higher proportion of diuretics use (P<0.05). Multivariate analysis revealed that SUA (OR: 1.004, 95% CI: 1.000–1.007, P=0.048), platelet count (OR: 0.994, 95% CI: 0.989–1.000, P=0.045), hematocrit (OR: 0.921, 95% CI: 0.864–0.981, P=0.011) and concomitant P2Y12 receptor inhibitors use (OR: 1.965, 95% CI: 1.075–3.592, P=0.028) were correlated with HAPR. Spearman’s correlation analysis demonstrated an inverse association of LTA–AA with hematocrit (r=−0.234, P<0.001), hemoglobin (r=−0.209, P<0.001) and estimated glomerular filtration rate (r=−0.132, P=0.031).Conclusion: SUA, platelet count, hematocrit and P2Y12 receptor inhibitors use were independently correlated with HAPR. These parameters might provide novel therapeutic targets for optimizing antiplatelet therapy. Keywords: aspirin, platelet reactivity, elderly, risk factors, coronary artery diseaseZhang JWLiu WWMcCaffrey TAHe XQLiang WYChen XHFeng XRFu SWLiu MLDove Medical Pressarticlehigh on-aspirin platelet reactivityelderlyrisk factorsGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 12, Pp 1271-1279 (2017)
institution DOAJ
collection DOAJ
language EN
topic high on-aspirin platelet reactivity
elderly
risk factors
Geriatrics
RC952-954.6
spellingShingle high on-aspirin platelet reactivity
elderly
risk factors
Geriatrics
RC952-954.6
Zhang JW
Liu WW
McCaffrey TA
He XQ
Liang WY
Chen XH
Feng XR
Fu SW
Liu ML
Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
description JW Zhang,1 WW Liu,1 Timothy A McCaffrey,2 XQ He,1 WY Liang,1 XH Chen,1 XR Feng,1 Sidney W Fu,2 ML Liu1 1Department of Geriatrics, Peking University First Hospital, Beijing, China; 2Department of Medicine, George Washington University Medical Center, Washington, DC, USA Objectives: Previous studies have illustrated the link between high on-aspirin platelet reactivity (HAPR) with increasing thrombotic risks. The aim of our study was to investigate relative risk factors of HAPR in elderly patients with coronary artery disease.Methods: Elderly, hospitalized coronary artery disease patients on regular aspirin treatment were enrolled from January 2014 to September 2016. Medical records of each patient were collected, including demographic information, cardiovascular risk factors, concomitant drugs and routine biological parameters. Arachidonic acid (AA, 0.5 mg/mL) and adenosine diphosphate (ADP, 5 µmol/L) induced platelet aggregation were measured via light transmission assay (LTA) to evaluate antiplatelet responses, referred as LTA–AA and LTA–ADP.Results: A total of 275 elderly patients were included, with mean age of 77.2±8.1 years, and males accounted for 81.8%. HAPR was defined as LTA–AA in the upper quartile of the enrolled population. HAPR patients tended to have lower renal function (P=0.052). Higher serum uric acid (SUA) level, as well as lower platelet count, hemoglobin and hematocrit were observed in HAPR patients, with a higher proportion of diuretics use (P<0.05). Multivariate analysis revealed that SUA (OR: 1.004, 95% CI: 1.000–1.007, P=0.048), platelet count (OR: 0.994, 95% CI: 0.989–1.000, P=0.045), hematocrit (OR: 0.921, 95% CI: 0.864–0.981, P=0.011) and concomitant P2Y12 receptor inhibitors use (OR: 1.965, 95% CI: 1.075–3.592, P=0.028) were correlated with HAPR. Spearman’s correlation analysis demonstrated an inverse association of LTA–AA with hematocrit (r=−0.234, P<0.001), hemoglobin (r=−0.209, P<0.001) and estimated glomerular filtration rate (r=−0.132, P=0.031).Conclusion: SUA, platelet count, hematocrit and P2Y12 receptor inhibitors use were independently correlated with HAPR. These parameters might provide novel therapeutic targets for optimizing antiplatelet therapy. Keywords: aspirin, platelet reactivity, elderly, risk factors, coronary artery disease
format article
author Zhang JW
Liu WW
McCaffrey TA
He XQ
Liang WY
Chen XH
Feng XR
Fu SW
Liu ML
author_facet Zhang JW
Liu WW
McCaffrey TA
He XQ
Liang WY
Chen XH
Feng XR
Fu SW
Liu ML
author_sort Zhang JW
title Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
title_short Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
title_full Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
title_fullStr Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
title_full_unstemmed Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
title_sort predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/c006466b426748b89b4de988d64cc73d
work_keys_str_mv AT zhangjw predictorsofhighonaspirinplateletreactivityinelderlypatientswithcoronaryarterydisease
AT liuww predictorsofhighonaspirinplateletreactivityinelderlypatientswithcoronaryarterydisease
AT mccaffreyta predictorsofhighonaspirinplateletreactivityinelderlypatientswithcoronaryarterydisease
AT hexq predictorsofhighonaspirinplateletreactivityinelderlypatientswithcoronaryarterydisease
AT liangwy predictorsofhighonaspirinplateletreactivityinelderlypatientswithcoronaryarterydisease
AT chenxh predictorsofhighonaspirinplateletreactivityinelderlypatientswithcoronaryarterydisease
AT fengxr predictorsofhighonaspirinplateletreactivityinelderlypatientswithcoronaryarterydisease
AT fusw predictorsofhighonaspirinplateletreactivityinelderlypatientswithcoronaryarterydisease
AT liuml predictorsofhighonaspirinplateletreactivityinelderlypatientswithcoronaryarterydisease
_version_ 1718401818355040256